Brigida E. Annicchiarico
Sapienza University of Rome
49 Papers
245 Citations
Brigida E. Annicchiarico is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Medicine & Cirrhosis. The author has an hindex of 12, co-authored 43 publications. Previous affiliations of Brigida E. Annicchiarico include Agostino Gemelli University Polyclinic & Catholic University of the Sacred Heart.
Chat about Author
Papers
Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study.
A. Iacobellis,Massimo Siciliano,Francesco Perri,Brigida E. Annicchiarico,Gioacchino Leandro,Nazario Caruso,L. Accadia,Giuseppe Bombardieri,Angelo Andriulli +8 more
TL;DR: In decompensated cirrhotics, HCV clearance by therapy is life-saving and reduces disease progression and early separation of SVR patients from both non-responders and controls at approximately 6 months.
204
Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers.
Lucia Cerrito,Brigida E. Annicchiarico,Roberto Iezzi,Antonio Gasbarrini,Maurizio Pompili,Francesca Romana Ponziani +5 more
TL;DR: It is extremely important to focus on the most adequate strategy to be applied to each group of PVTT patients, according to the degree of portal system involvement, tumor biological aggressiveness, complications caused by portal hypertension, patient’s clinical features and tolerance to antineoplastic treatments.
116
Gut microbiota and metabolic syndrome
Francesca D'Aversa,Annalisa Tortora,Gianluca Ianiro,Francesca Romana Ponziani,Brigida E. Annicchiarico,Antonio Gasbarrini +5 more
TL;DR: A deeper knowledge of a specific microbiota profile associated with increased risk of metabolic disease and its subsequent modification induced by prebiotics, probiotics or targeted antibiotics will be necessary for the development of new therapeutic approaches in the treatment of metabolic syndrome.
88
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation
Alfonso Wolfango Avolio,Massimo Siciliano,Raffaella Barbarino,E. Nure,Brigida E. Annicchiarico,Antonio Gasbarrini,Salvatore Agnes,Marco Castagneto +7 more
- 01 Jul 2008
TL;DR: The OPI predicted outcomes better than DRI, increasing the gap in the long-term graft survival between the low- and the high-risk class and the inclusion of the MELD in the new index allowed better prediction of graft survival.
32